Clinical Trial: A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 2, Single-Center, Randomized, Double-Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution in the Environment and During Challenge in the CAE(
Brief Summary: The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.
Detailed Summary:
Sponsor: Mitotech, SA
Current Primary Outcome:
- Fluorescein Staining [ Time Frame: Day 29 ]
- Worst Dry Eye Symptom [ Time Frame: Day 29 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mitotech, SA
Dates:
Date Received: April 17, 2014
Date Started: April 2014
Date Completion:
Last Updated: July 21, 2014
Last Verified: July 2014
